Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
p21 Monoclonal Antibody (HJ21 (WA-1)), Invitrogen™
Mouse Monoclonal Antibody
Supplier: Thermo Scientific MA513461
Description
MA5-13461 targets p21WAF1 in IF and WB applications and shows reactivity with Human and Rat samples. The MA5-13461 immunogen is human recombinant p21 protein.
p21 Monoclonal antibody specifically detects p21 in Human, Rat samples. It is validated for Immunocytochemistry, Western Blot.
Specifications
p21 | |
Monoclonal | |
0.2 mg/mL | |
PBS with 0.2% BSA and 0.09% sodium azide; pH 7.4 | |
P38936 | |
CDKN1A | |
Human recombinant p21 protein | |
500 μL | |
Primary | |
Human, Rat | |
Liquid |
Immunocytochemistry, Western Blot | |
HJ21 (WA-1) | |
Unconjugated | |
CDKN1A | |
Activating Fragment 1; CAP20; cdk inhibitor CIP1; cdk inhibitor CIP1 (p21); CDKI; CDK-interacting protein 1; CDK-interaction protein 1; Cdkn1; CDKN1A; CDNK1A; CIP1; Cip1); cyclin dependent kinase inhibitor 1A; cyclin-dependent kinase inhibitor 1; cyclin-dependent kinase inhibitor 1A; Cyclin-dependent kinase inhibitor 1A (p21; cyclin-dependent kinase inhibitor 1A (P21); cyclin-dependent kinase inhibitor 1A (p21, Cip1); cyclin-dependent kinase inhibitor 1A variant 1; cyclin-dependent kinase inhibitor 1A variant 2; DNA synthesis inhibitor; MDA6; MDA-6; melanoma differentiation associated protein 6; melanoma differentiation-associated protein; Melanoma differentiation-associated protein 6; OTTHUMP00000016298; p21; p21<WAF1/CIP1>; p21Cip1; p21Cip1/Waf1; p21WAF; PIC1; putative cyclin-dependent kinase inhibitor 1A (p21/WAF1/CIP1); SDI1; SLC12A9; UV96; WAF1; Wild type p53 activated fragment 1 (WAF1); wild-type p53-activated fragment 1 | |
Mouse | |
Protein G | |
RUO | |
1026, 114851 | |
4° C | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction